PDE3 Inhibitors (Eli Lilly)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NamePDE3 Inhibitors (Eli Lilly)
Drug Alias NamePDE3 inhibitors (ICOS)PDE modulators (ICOS)CC-181351CC-27659
ClassificationSmall molecules
Mechanisms of ActionPhosphodiesterase 3 inhibitorsNeuroprotectants
TargetsPhosphodiesterase 3
Therapy Area/IndicationsInflammationMetabolic DiseasesNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIcos Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEli Lilly And CompanyIcos Corp
Active IndicationsN/A
Inactive IndicationsInflammationMetabolic DiseasesNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A